Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dihua Yu

Showing results (41-50 of 154) with videos related to

Pageof 16
Sort By:
The Journal of Biological Chemistry|November 26, 2004
Transcriptional repression of protein kinase Calpha via Sp1 by wild type p53 is involved in inhibition of multidrug resistance 1 P-glycoprotein phosphorylationMaocheng Zhan, Dihua Yu, Juehui Liu, et al.
Journal of Biomedical Science|July 5, 2020
The impact of PD-L1 N-linked glycosylation on cancer therapy and clinical diagnosisYing-Nai Wang, Heng-Huan Lee, Jennifer L Hsu, et al.
Plos One|October 23, 2010
Tissue transglutaminase promotes drug resistance and invasion by inducing mesenchymal transition in mammary epithelial cellsAnupam Kumar, Jia Xu, Samuel Brady, et al.
Breast Cancer Research : BCR|January 10, 2012
Evidence that GTP-binding domain but not catalytic domain of transglutaminase 2 is essential for epithelial-to-mesenchymal transition in mammary epithelial cellsAnupam Kumar, Jia Xu, Bokyung Sung, et al.
Cancer Research|March 15, 2008
14-3-3 zeta down-regulates p53 in mammary epithelial cells and confers luminal fillingChristopher G Danes, Shannon L Wyszomierski, Jing Lu, et al.
Cancer|September 26, 2003
Combined trastuzumab and paclitaxel treatment better inhibits ErbB-2-mediated angiogenesis in breast carcinoma through a more effective inhibition of Akt than either treatment aloneKristine S Klos, Xiaoyan Zhou, Sangkyou Lee, et al.
Cancer Research|May 20, 2004
Lineage infidelity of MDA-MB-435 cells: expression of melanocyte proteins in a breast cancer cell lineShankar Sellappan, Rebecca Grijalva, Xiaoyan Zhou, et al.
Journal of Biomedical Optics|September 5, 2013
Needle-based fluorescence endomicroscopy via structured illumination with a plastic, achromatic objectiveMatthew Kyrish, Jessica Dobbs, Shalini Jain, et al.
American Journal of Cancer Research|February 1, 2021
Nuclear translocation of the receptor tyrosine kinase c-MET reduces the treatment efficacies of olaparib and gemcitabine in pancreatic ductal adenocarcinoma cellsYuan Gao, Mei-Kuang Chen, Yu-Yi Chu, et al.
Molecular Cancer Research : MCR|April 18, 2009
ErbB2-mediated Src and signal transducer and activator of transcription 3 activation leads to transcriptional up-regulation of p21Cip1 and chemoresistance in breast cancer cellsValerie S Hawthorne, Wen-Chien Huang, Christopher L Neal, et al.
Pageof 16

Showing results (41-50 of 154) with videos related to

Sort By:
Pageof 16
The Journal of Biological Chemistry|November 26, 2004
Transcriptional repression of protein kinase Calpha via Sp1 by wild type p53 is involved in inhibition of multidrug resistance 1 P-glycoprotein phosphorylationMaocheng Zhan, Dihua Yu, Juehui Liu, et al.
Journal of Biomedical Science|July 5, 2020
The impact of PD-L1 N-linked glycosylation on cancer therapy and clinical diagnosisYing-Nai Wang, Heng-Huan Lee, Jennifer L Hsu, et al.
Plos One|October 23, 2010
Tissue transglutaminase promotes drug resistance and invasion by inducing mesenchymal transition in mammary epithelial cellsAnupam Kumar, Jia Xu, Samuel Brady, et al.
Breast Cancer Research : BCR|January 10, 2012
Evidence that GTP-binding domain but not catalytic domain of transglutaminase 2 is essential for epithelial-to-mesenchymal transition in mammary epithelial cellsAnupam Kumar, Jia Xu, Bokyung Sung, et al.
Cancer Research|March 15, 2008
14-3-3 zeta down-regulates p53 in mammary epithelial cells and confers luminal fillingChristopher G Danes, Shannon L Wyszomierski, Jing Lu, et al.
Cancer|September 26, 2003
Combined trastuzumab and paclitaxel treatment better inhibits ErbB-2-mediated angiogenesis in breast carcinoma through a more effective inhibition of Akt than either treatment aloneKristine S Klos, Xiaoyan Zhou, Sangkyou Lee, et al.
Cancer Research|May 20, 2004
Lineage infidelity of MDA-MB-435 cells: expression of melanocyte proteins in a breast cancer cell lineShankar Sellappan, Rebecca Grijalva, Xiaoyan Zhou, et al.
Journal of Biomedical Optics|September 5, 2013
Needle-based fluorescence endomicroscopy via structured illumination with a plastic, achromatic objectiveMatthew Kyrish, Jessica Dobbs, Shalini Jain, et al.
American Journal of Cancer Research|February 1, 2021
Nuclear translocation of the receptor tyrosine kinase c-MET reduces the treatment efficacies of olaparib and gemcitabine in pancreatic ductal adenocarcinoma cellsYuan Gao, Mei-Kuang Chen, Yu-Yi Chu, et al.
Molecular Cancer Research : MCR|April 18, 2009
ErbB2-mediated Src and signal transducer and activator of transcription 3 activation leads to transcriptional up-regulation of p21Cip1 and chemoresistance in breast cancer cellsValerie S Hawthorne, Wen-Chien Huang, Christopher L Neal, et al.
Pageof 16